These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25616716)

  • 61. The Janus Faces of IL-6 in GN.
    Salama AD; Little MA
    J Am Soc Nephrol; 2015 Jul; 26(7):1480-2. PubMed ID: 25655069
    [No Abstract]   [Full Text] [Related]  

  • 62. Diabetes. IL-6 mediates the protective effects of exercise on β cells.
    Osório J
    Nat Rev Endocrinol; 2015 Apr; 11(4):193. PubMed ID: 25666494
    [No Abstract]   [Full Text] [Related]  

  • 63. IL-6 originated from breast cancer tissue-derived mesenchymal stromal cells may contribute to carcinogenesis.
    Sağlam Ö; Ünal ZS; Subaşı C; Ulukaya E; Karaöz E
    Tumour Biol; 2015 Jul; 36(7):5667-77. PubMed ID: 25697898
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The transcription factor nuclear factor interleukin 6 mediates pro- and anti-inflammatory responses during LPS-induced systemic inflammation in mice.
    Schneiders J; Fuchs F; Damm J; Herden C; Gerstberger R; Soares DM; Roth J; Rummel C
    Brain Behav Immun; 2015 Aug; 48():147-64. PubMed ID: 25813145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biologic basis for interleukin-1 in disease.
    Dinarello CA
    Blood; 1996 Mar; 87(6):2095-147. PubMed ID: 8630372
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pro-inflammatory cytokines: The link between obesity and osteoarthritis.
    Wang T; He C
    Cytokine Growth Factor Rev; 2018 Dec; 44():38-50. PubMed ID: 30340925
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.
    Murakami M; Kamimura D; Hirano T
    Immunity; 2019 Apr; 50(4):812-831. PubMed ID: 30995501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
    Johnson DE; O'Keefe RA; Grandis JR
    Nat Rev Clin Oncol; 2018 Apr; 15(4):234-248. PubMed ID: 29405201
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IL-6 in inflammation, autoimmunity and cancer.
    Hirano T
    Int Immunol; 2021 Mar; 33(3):127-148. PubMed ID: 33337480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting Interleukin-6 Signaling in Clinic.
    Kang S; Tanaka T; Narazaki M; Kishimoto T
    Immunity; 2019 Apr; 50(4):1007-1023. PubMed ID: 30995492
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape.
    Liu F; Wang L; Perna F; Nimer SD
    Nat Rev Cancer; 2016 Jun; 16(6):359-72. PubMed ID: 27220480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting JAK kinase in solid tumors: emerging opportunities and challenges.
    Buchert M; Burns CJ; Ernst M
    Oncogene; 2016 Feb; 35(8):939-51. PubMed ID: 25982279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting STAT3 in Cancer Immunotherapy.
    Zou S; Tong Q; Liu B; Huang W; Tian Y; Fu X
    Mol Cancer; 2020 Sep; 19(1):145. PubMed ID: 32972405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets.
    Park JH; Pyun WY; Park HW
    Cells; 2020 Oct; 9(10):. PubMed ID: 33081387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The JAK/STAT signaling pathway: from bench to clinic.
    Hu X; Li J; Fu M; Zhao X; Wang W
    Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling.
    Timper K; Denson JL; Steculorum SM; Heilinger C; Engström-Ruud L; Wunderlich CM; Rose-John S; Wunderlich FT; Brüning JC
    Cell Rep; 2017 Apr; 19(2):267-280. PubMed ID: 28402851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IL-6 pathway in the liver: From physiopathology to therapy.
    Schmidt-Arras D; Rose-John S
    J Hepatol; 2016 Jun; 64(6):1403-15. PubMed ID: 26867490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
    Jones SA; Jenkins BJ
    Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-6: A Masterplayer in the Cytokine Network.
    Uciechowski P; Dempke WCM
    Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors.
    Kaur S; Bansal Y; Kumar R; Bansal G
    Bioorg Med Chem; 2020 Mar; 28(5):115327. PubMed ID: 31992476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.